Drug manufacturer Teva Canada Ltd. is recalling two lots of its Teva-Pregabalin 150-milligram capsules after routine testing identified that some pills could be contaminated with the drug sertraline.
The two lots affected by the recall are 100070495 (100-capsule bottle) and 100068913 (500-capsule bottle), which were first sold in Canada in September 2025 and expire on July 31, 2027.
“Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure,” Health Canada said in a recall notice.
Anaphylactic reaction symptoms can be fatal and may include shortness of breath, wheezing, or difficulty breathing; swelling of the eyelids, face, lips, mouth, tongue, or throat; uncontrolled shaking, fainting, or dizziness; trouble swallowing or speaking; and widespread rash or hives….